Cerence Inc. (NASDAQ:CRNC) and Renault Group today announced they have signed a multi-year agreement to build the automaker's next-generation co-pilot.
Cerence and Renault have teamed to
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and its subsidiary, GW Pharmaceuticals have begun construction of its new, state-of-the-art manufacturing facility at Kent Science Park (KSP) in Sittingbourne, UK, with an investment of over $100 million.&nb